ljc 10627 has been researched along with Bacteremia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hino, T; Hitomi, S; Kikuchi, M; Kodaira, Y; Tamai, K; Urata, T; Yoda, Y | 1 |
| Araki, N; Harada, Y; Hasegawa, H; Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Morinaga, Y; Yamada, K; Yamamoto, Y; Yanagihara, K | 1 |
| Jones, RN; Sader, HS | 1 |
3 other study(ies) available for ljc 10627 and Bacteremia
| Article | Year |
|---|---|
Bacteremia caused by Desulfovibrio fairfieldensis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cefazolin; Desulfovibrio; Desulfovibrionaceae Infections; Female; Humans; Microbial Sensitivity Tests; RNA, Bacterial; RNA, Ribosomal, 16S; Thienamycins | 2008 |
In vivo efficacy and pharmacokinetics of biapenem in a murine model of ventilator-associated pneumonia with Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Colony Count, Microbial; Disease Models, Animal; Histocytochemistry; Lung; Male; Meropenem; Mice; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms; Statistics, Nonparametric; Thienamycins | 2012 |
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Ceftazidime; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 1993 |